Noninvasive Prenatal Testing: Impact on Genetic Counseling, Invasive Prenatal Diagnosis, and Trisomy 21 Detection

Journal of Clinical Ultrasound

Volumn 43, Issue 1, 2015, Pages 1-6

  Wax, Joseph R ^a   Cartin, Angelina ^a   Chard, Renée ^a   Lucas, F Lee ^a   Pinette, Michael G ^a  

^a MAINE MEDICAL CENTER   (United States)

Author keywords

Aneuploidy screening; Cell free fetal DNA; Down syndrome; Trisomy 21; Ultrasonography

Indexed keywords

ADULT; AMNIOCENTESIS; CHORION VILLUS SAMPLING; COHORT ANALYSIS; DOWN SYNDROME; FEMALE; FETUS ECHOGRAPHY; GENETIC COUNSELING; HUMAN; PREGNANCY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; AMNIOCENTESIS; CHORIONIC VILLI SAMPLING; COHORT STUDIES; DOWN SYNDROME; FEMALE; GENETIC COUNSELING; HUMANS; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 84914813271     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.22243     Document Type: Article

References (12)

1. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913.
2. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137.e1.
3. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011:204:205.e1.
4. Porreco RP, Garite TJ, Maurel K, et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol 2014;211:365.e1.
5. Friel LA, Czerwinski JL, Singletary CN. The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine. Am J Perinatol 2014;31:759.
6. Chetty S, Garabedian MJ, Norton ME. Uptake on noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenat Diagn 2013;33:542.
7. Muller PR, Cocciolone R, Haan EA et al. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005. Am J Obstet Gynecol 2007;196:315.e1.
8. Devers PL, Cronister A, Ormond KE, et al. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. J Genet Couns 2013;22:291.
9. Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013;15:395.
10. Benn P, Borell A, Chiu R, et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2013;33:622.
11. American College of Obstetricians and Gynecologists Committee on Genetics and the Society for Maternal Fetal Medicine Publications Committee. Committee opinion number 545. Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012;120:1532.
12. Cohn GM, Gould M, Miller RC, et al. The importance of genetic counseling before amniocentesis. J Perinatol 1996;16:352.